Results 151 to 160 of about 113,618,068 (200)
Some of the next articles are maybe not open access.
CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer
Clinica Chimica Acta, 1991The individual and combined value of CA 15-3 and carcinoembryonic antigen (CEA) as breast cancer tumor markers was investigated in longitudinal studies. Patients included women at high risk for recurrence after primary therapy or undergoing treatment for metastatic disease.
A M, Dnistrian +4 more
openaire +2 more sources
Cancer-associated antigen CA 15-3 in the diagnostics of breast tumours
Scandinavian Journal of Clinical and Laboratory Investigation, 1988The serum concentration of the new marker CA 15-3 was determined by a kit method, which is based on the use of two different monoclonal antibodies 115D8 and DF3, in a coated tube immunoradiometric technique. The mean CA 15-3 values in breast cancer patients (n = 40) were significantly higher than in patients with benign breast disease (n = 52, p less ...
M, Eskelinen +4 more
openaire +2 more sources
International Journal of Clinical Oncology, 2008
Tumor markers are frequently used for screening and monitoring in oncology. We investigated the use of preoperative tumor marker (carcinoembryonic antigen [CEA] and carbohydrate antigen [CA] 15-3) levels in estimating the prognosis of breast cancer patients.We conducted a retrospective study in patients who underwent breast cancer surgery at National ...
Masahiro, Uehara +5 more
openaire +2 more sources
Tumor markers are frequently used for screening and monitoring in oncology. We investigated the use of preoperative tumor marker (carcinoembryonic antigen [CEA] and carbohydrate antigen [CA] 15-3) levels in estimating the prognosis of breast cancer patients.We conducted a retrospective study in patients who underwent breast cancer surgery at National ...
Masahiro, Uehara +5 more
openaire +2 more sources
Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 testing
Breast Cancer Research and Treatment, 2017Cancer antigens (CA) 15-3 and 27.29 are used in the clinical management of many breast cancer patients. Given that immunoassays for CA 15-3 and CA 27.29 target epitopes on the same glycoprotein-Mucin 1 (MUC1)-the present analysis was conducted to evaluate the potential concordance of tumor marker results when both tests were ordered by providers on the
David C, Lin, Jonathan R, Genzen
openaire +2 more sources
cclm, 1998
Abstract Cancer antigen 15–3 (CA 15–3), carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) were measured in 679 sera of breast cancer patients and in 94 sera of women without breast cancer. The tumour markers were determined using immunoluminometric assays (ILMA).
R, Findeisen +4 more
openaire +2 more sources
Abstract Cancer antigen 15–3 (CA 15–3), carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) were measured in 679 sera of breast cancer patients and in 94 sera of women without breast cancer. The tumour markers were determined using immunoluminometric assays (ILMA).
R, Findeisen +4 more
openaire +2 more sources
Cancer Research, 2023
Abstract Background: Cancer antigen 15-3 (CA 15-3) is the most commonly used tumor marker in patients with breast cancer (BC). However, the usefulness of CA 15-3 is still controversial and there is lack of evidence for its role in metastatic BC. We performed a retrospective analysis of the value of CA 15-3 for monitoring and diagnosis in
Henrik Lindman +3 more
openaire +1 more source
Abstract Background: Cancer antigen 15-3 (CA 15-3) is the most commonly used tumor marker in patients with breast cancer (BC). However, the usefulness of CA 15-3 is still controversial and there is lack of evidence for its role in metastatic BC. We performed a retrospective analysis of the value of CA 15-3 for monitoring and diagnosis in
Henrik Lindman +3 more
openaire +1 more source
Veterinary Research Communications, 2007
Marchesi, M.C., Conti, M.B., Pieramati, C., Mangili, V. and Fruganti, G. 2007. Assessment and Behavior of Alphafetoprotein (AFP), Antigen Cancer 15/3 (CA 15/3), Carcinembryonal Antigen (CEA) in Clinical Oncology of the Dog: Preliminary Study. Veterinary Research Communications, 31(Suppl.
MARCHESI, Maria Chiara +4 more
openaire +3 more sources
Marchesi, M.C., Conti, M.B., Pieramati, C., Mangili, V. and Fruganti, G. 2007. Assessment and Behavior of Alphafetoprotein (AFP), Antigen Cancer 15/3 (CA 15/3), Carcinembryonal Antigen (CEA) in Clinical Oncology of the Dog: Preliminary Study. Veterinary Research Communications, 31(Suppl.
MARCHESI, Maria Chiara +4 more
openaire +3 more sources
Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer
Klinische Wochenschrift, 1989Mucin-like cancer-associated antigen (MCA), a new tumor marker using the mouse monoclonal antibody b-12 is thought to be of value in the management of patients with breast cancer. In this study sera from 191 female patients with breast cancer (112 with progressive disease [PD] and 79 with no evidence of disease [NED]) were analyzed for MCA levels and ...
G G, Steger +4 more
openaire +2 more sources
International Journal of Gynecology & Obstetrics, 1993
To assess different strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens, including concomitant measurement of multiple tumor markers and serial measurement of CA 125.A combination of CA 125, CA 15-3, and TAG 72.3 was evaluated in serum samples from 217 of 1010 apparently healthy postmenopausal women ...
Jacobs, I. J., Oram, D. H., Bast, R. C.
openaire +3 more sources
To assess different strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens, including concomitant measurement of multiple tumor markers and serial measurement of CA 125.A combination of CA 125, CA 15-3, and TAG 72.3 was evaluated in serum samples from 217 of 1010 apparently healthy postmenopausal women ...
Jacobs, I. J., Oram, D. H., Bast, R. C.
openaire +3 more sources